BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 26158518)

  • 1. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
    Felzen V; Hiebel C; Koziollek-Drechsler I; Reißig S; Wolfrum U; Kögel D; Brandts C; Behl C; Morawe T
    Cell Death Dis; 2015 Jul; 6(7):e1812. PubMed ID: 26158518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells.
    Chang EC; Frasor J; Komm B; Katzenellenbogen BS
    Endocrinology; 2006 Oct; 147(10):4831-42. PubMed ID: 16809442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target.
    Skliris GP; Leygue E; Watson PH; Murphy LC
    J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):1-10. PubMed ID: 18243688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.
    Gougelet A; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):110-22. PubMed ID: 17478088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
    Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
    Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
    Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and role of estrogen receptor alpha and beta in medullary thyroid carcinoma: different roles in cancer growth and apoptosis.
    Cho MA; Lee MK; Nam KH; Chung WY; Park CS; Lee JH; Noh T; Yang WI; Rhee Y; Lim SK; Lee HC; Lee EJ
    J Endocrinol; 2007 Nov; 195(2):255-63. PubMed ID: 17951536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of Estrogen Receptor β modulates the response of breast cancer cells to therapeutic agents.
    Pons DG; Torrens-Mas M; Nadal-Serrano M; Sastre-Serra J; Roca P; Oliver J
    Int J Biochem Cell Biol; 2015 Sep; 66():85-94. PubMed ID: 26232188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C; Matthews J; Tujague M; Wan J; Ström A; Toresson G; Lam EW; Cheng G; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2007 Apr; 67(8):3955-62. PubMed ID: 17440111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma.
    Gruvberger-Saal SK; Bendahl PO; Saal LH; Laakso M; Hegardt C; Edén P; Peterson C; Malmström P; Isola J; Borg A; Fernö M
    Clin Cancer Res; 2007 Apr; 13(7):1987-94. PubMed ID: 17404078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of apoptosis-associated genes by estrogen receptor alpha in human neuroblastoma cells.
    Brendel A; Felzen V; Morawe T; Manthey D; Behl C
    Restor Neurol Neurosci; 2013; 31(2):199-211. PubMed ID: 23271418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
    Lee SO; Nadiminty N; Wu XX; Lou W; Dong Y; Ip C; Onate SA; Gao AC
    Cancer Res; 2005 Apr; 65(8):3487-92. PubMed ID: 15833885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells.
    Yu X; Li R; Shi W; Jiang T; Wang Y; Li C; Qu X
    Biomed Pharmacother; 2016 Feb; 77():37-44. PubMed ID: 26796263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Phytoestrogen Genistein Affects Breast Cancer Cells Treatment Depending on the ERα/ERβ Ratio.
    Pons DG; Nadal-Serrano M; Torrens-Mas M; Oliver J; Roca P
    J Cell Biochem; 2016 Jan; 117(1):218-29. PubMed ID: 26100284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.